Transplantation of embryonic stem cell-derived neural stem cells for spinal cord injury in adult mice. 2005

Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
Department of Neurosurgery, Nara Medical University, Nara, Japan.

OBJECTIVE To investigate the efficacy of embryonic stem cell-derived neural stem cells (NSCs) for spinal cord injury (SCI) in mice and whether a combination treatment with thyroid hormone provides a more effective ES cell-based therapy. METHODS Nestin-positive NSCs were induced from undifferentiated mouse ES cells by a step-by-step culture and used as grafts. Thirty-six mice were subjected to an SCI at Th10 and divided into three groups of 12. Graft cells were transplanted into the injury site 10 days after injury. Group 1 mice were left under observation without receiving graft cells, while mice in Group 2 received 2 x 104 graft cells, and those in Group 3 received 2 x 104 graft cells and were treated with a continuous intraperitoneal injection of thyroxin using osmotic mini-pumps. Behavioral improvement was assessed by a scoring system throughout the experimental period until post-transplantation day (PD) 28. RESULTS Mice in Groups 2 and 3 demonstrated an improved behavioral function, as compared to those in Group 1 after PD 14. There was no significant difference in behavioral recovery between Groups 2 and 3. CONCLUSIONS Transplantation of ES-NSCs into the injury site was effective for SCI, while thyroxine did not deliver additional effectiveness.

UI MeSH Term Description Entries
D007381 Intermediate Filament Proteins Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein. Fibroblast Intermediate Filament Proteins,Filament Proteins, Intermediate,Proteins, Intermediate Filament
D009419 Nerve Tissue Proteins Proteins, Nerve Tissue,Tissue Proteins, Nerve
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009836 Oligodendroglia A class of large neuroglial (macroglial) cells in the central nervous system. Oligodendroglia may be called interfascicular, perivascular, or perineuronal (not the same as SATELLITE CELLS, PERINEURONAL of GANGLIA) according to their location. They form the insulating MYELIN SHEATH of axons in the central nervous system. Interfascicular Oligodendroglia,Oligodendrocytes,Perineuronal Oligodendroglia,Perineuronal Satellite Oligodendroglia Cells,Perivascular Oligodendroglia,Satellite Cells, Perineuronal, Oligodendroglia,Perineuronal Satellite Oligodendrocytes,Interfascicular Oligodendroglias,Oligodendrocyte,Oligodendrocyte, Perineuronal Satellite,Oligodendrocytes, Perineuronal Satellite,Oligodendroglia, Interfascicular,Oligodendroglia, Perineuronal,Oligodendroglia, Perivascular,Perineuronal Satellite Oligodendrocyte,Satellite Oligodendrocyte, Perineuronal,Satellite Oligodendrocytes, Perineuronal
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D005260 Female Females
D005904 Glial Fibrillary Acidic Protein An intermediate filament protein found only in glial cells or cells of glial origin. MW 51,000. Glial Intermediate Filament Protein,Astroprotein,GFA-Protein,Glial Fibrillary Acid Protein,GFA Protein

Related Publications

Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
January 2015, Stem cells and development,
Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
January 2018, Stem cells international,
Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
November 2005, Rinsho shinkeigaku = Clinical neurology,
Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
March 2011, PloS one,
Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
January 2016, Cell transplantation,
Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
January 2021, Cell transplantation,
Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
May 2007, Journal of neurotrauma,
Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
February 2010, Brain : a journal of neurology,
Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
January 2015, Neural regeneration research,
Hajime Kimura, and Masahide Yoshikawa, and Ryousuke Matsuda, and Hayato Toriumi, and Fumihiko Nishimura, and Hidehiro Hirabayashi, and Hiroyuki Nakase, and Shoichiro Kawaguchi, and Shigeaki Ishizaka, and Toshisuke Sakaki
March 2018, Cellular and molecular life sciences : CMLS,
Copied contents to your clipboard!